NECLIFEUpdated 2 Sept 2026, 4:17

Nectar Lifesciences Ltd.

NECLIFEUpdated 2 Sept 2026, 4:17

Market Cap

₹236Cr.

Current Price

₹12.1

High / Low

₹22.5/9.20

ROE-31.3%

ROCE0.05%

Book Value₹30.0

Face Value₹1.00

Dividend Yield0.00%

About

Incorporated in 1995, Nectar Lifesciences Ltd manufactures APIs and Formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Annual statement₹ Cr.

As of Jun 2026%

Ownership over time%

Assets & liabilities₹ Cr.

Operating, investing & financing₹ Cr.

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	99	107	112	119	74	61	89	98	67	82	—	—
Inventory Days	253	260	270	226	150	192	185	197	212	215	—	—
Days Payable	146	154	167	142	79	104	108	112	100	127	—	—
Cash Conversion Cycle	207	213	215	203	145	149	166	183	178	170	—	—
Working Capital Days	40	41	46	67	46	53	6	73	77	63	—	—
ROCE %	11%	10%	10%	9%	10%	8%	3%	5%	-0%	6%	0%	0%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 2 September 2026 at 4:17